• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物诱导的假性过敏:病因和机制的综述。

Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms.

机构信息

Department of Pharmacology, Institute of Materia Medica, Zhejiang Academy of Medical Sciences, Hangzhou, PR China.

出版信息

Pharmacology. 2018;101(1-2):104-110. doi: 10.1159/000479878. Epub 2017 Nov 15.

DOI:10.1159/000479878
PMID:29136631
Abstract

Adverse drug reactions occur frequently and can trigger pseudoallergy, which has become a serious threat to public health. Pseudoallergy is a typical non-immune anaphylactic reaction characterized by the independence of antigen-specific immune responses. In the clinic, pseudoallergy is often elicited by the first dose of medication, and here lies its unpredictability and occasional lethal outcome. However, the mechanisms of pseudoallergy are not well understood. This review focusses on the causes and mechanisms of pseudoallergy induced by drugs. Two categories of mechanisms will be considered, namely, (1) complement activation-related pseudoallergy and (2) mast cell activation-related pseudoallergy. The factors that induce pseudoallergy include opioid drugs, complement activation-related pseudoallergenic drugs, nonsteroidal anti-inflammatory drugs and traditional Chinese medicine injections.

摘要

药物不良反应发生率高,可诱发假性过敏反应,成为严重的公共卫生威胁。假性过敏反应是一种典型的非免疫性过敏反应,其特征是抗原特异性免疫反应的独立性。临床上,假性过敏反应常由首次用药引起,这使其具有不可预测性和偶发性致命性。然而,假性过敏反应的机制尚不清楚。本综述重点讨论药物引起的假性过敏反应的原因和机制。将考虑两种机制,即(1)补体激活相关假性过敏反应和(2)肥大细胞激活相关假性过敏反应。引起假性过敏反应的因素包括阿片类药物、补体激活相关假性致敏药物、非甾体抗炎药和中药注射液。

相似文献

1
Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms.药物诱导的假性过敏:病因和机制的综述。
Pharmacology. 2018;101(1-2):104-110. doi: 10.1159/000479878. Epub 2017 Nov 15.
2
Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals.补体激活相关假性过敏:纳米药物和生物制剂引发的血液应激反应。
Mol Immunol. 2014 Oct;61(2):163-73. doi: 10.1016/j.molimm.2014.06.038. Epub 2014 Aug 12.
3
A novel method for evaluating pseudoallergy based on β-hexosaminidase and its application for traditional Chinese medicine injections.一种基于β-己糖胺酶的拟过敏评估新方法及其在中药注射液中的应用。
J Sep Sci. 2024 Jan;47(1):e2300545. doi: 10.1002/jssc.202300545.
4
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.由脂质体、静脉注射药物的胶束载体和放射性造影剂引起的补体激活相关假过敏反应。
Crit Rev Ther Drug Carrier Syst. 2001;18(6):567-606.
5
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.不同表面电荷和聚乙二醇化的脂质体补体激活相关假性过敏反应的特点:猪和大鼠反应的比较。
J Control Release. 2014 Dec 10;195:2-10. doi: 10.1016/j.jconrel.2014.08.009. Epub 2014 Aug 19.
6
[Methodology for preclinical assay of pseudoallergy of injectable drugs (I)--mouse model for assay of pseudoallergy induced by injections].[注射用药物假过敏的临床前检测方法(I)——注射诱导假过敏检测的小鼠模型]
Zhongguo Zhong Yao Za Zhi. 2012 Jul;37(13):1865-70.
7
[Methodology for preclinical assay of pseudoallergy of injectable drugs (II) rat model for assay of cutaneous pseudoallergy induced by injections].[注射用药物假性过敏的临床前检测方法(II) 注射引起的皮肤假性过敏检测的大鼠模型]
Zhongguo Zhong Yao Za Zhi. 2012 Jul;37(13):1871-4.
8
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.补体激活作为一个与仿制药脂质体及其他纳米颗粒药物研发相关的生物等效性问题。
Biochem Biophys Res Commun. 2015 Dec 18;468(3):490-7. doi: 10.1016/j.bbrc.2015.06.177. Epub 2015 Jul 14.
9
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.治疗性脂质体和其他基于脂质赋形剂的治疗产品激活补体:预测和预防。
Adv Drug Deliv Rev. 2011 Sep 16;63(12):1020-30. doi: 10.1016/j.addr.2011.06.017. Epub 2011 Jul 14.
10
Nanomedicine safety in preclinical and clinical development: focus on idiosyncratic injection/infusion reactions.纳米医学在临床前和临床开发中的安全性:关注特发性注射/输注反应。
Drug Discov Today. 2018 May;23(5):1034-1042. doi: 10.1016/j.drudis.2017.11.006. Epub 2017 Nov 13.

引用本文的文献

1
Adaptation and Linguistic Validation of Angioedema PROMs in Latvian for Assessing Recurrent Angioedema.用于评估复发性血管性水肿的拉脱维亚语血管性水肿患者报告结局量表的改编与语言验证
J Clin Med. 2025 Feb 19;14(4):1375. doi: 10.3390/jcm14041375.
2
Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies.解析补体介导的过敏反应的复杂性:治疗策略的新兴进展综述
Arch Dermatol Res. 2025 Feb 19;317(1):439. doi: 10.1007/s00403-025-03971-z.
3
Amphotericin B for injection triggers degranulation of human LAD2 mast cells by MRGPRX2 and pseudo-allergic reactions in mice via MRGPRB2 activation.
注射用两性霉素B通过MRGPRX2触发人LAD2肥大细胞脱颗粒,并通过激活MRGPRB2在小鼠中引发类过敏反应。
Immunol Res. 2024 Dec;72(6):1337-1349. doi: 10.1007/s12026-024-09532-2. Epub 2024 Sep 3.
4
Contrast efficacy of novel phase convertible nanodroplets for safe CEUS imaging.新型相转化纳米液滴用于安全 CEUS 成像的对比疗效。
Sci Rep. 2024 Jul 12;14(1):16126. doi: 10.1038/s41598-024-66163-1.
5
Allergic reactions to the Ad26.COV2.S vaccine in South Africa.南非对Ad26.COV2.S疫苗的过敏反应。
J Allergy Clin Immunol Glob. 2021 Dec 9;1(1):2-8. doi: 10.1016/j.jacig.2021.12.002. eCollection 2022 Feb.
6
The Role of Mast Cells in the Induction and Maintenance of Inflammation in Selected Skin Diseases.肥大细胞在某些皮肤疾病中炎症的诱导和维持中的作用。
Int J Mol Sci. 2023 Apr 10;24(8):7021. doi: 10.3390/ijms24087021.
7
Anaphylactic reactions after COVID-19 vaccination in Germany.德国新冠疫苗接种后的过敏反应。
Allergol Select. 2023 Mar 31;7:90-100. doi: 10.5414/ALX02374E. eCollection 2023.
8
Molecular Mechanisms of Scombroid Food Poisoning.鲭鱼中毒的分子机制。
Int J Mol Sci. 2023 Jan 3;24(1):809. doi: 10.3390/ijms24010809.
9
Ondansetron-induced pseudoallergy with non-ischemic myocardial injury: A rare case report of Kounis syndrome.昂丹司琼诱发的假性过敏伴非缺血性心肌损伤:一例罕见的库尼斯综合征病例报告。
Clin Case Rep. 2022 Dec 22;10(12):e6781. doi: 10.1002/ccr3.6781. eCollection 2022 Dec.
10
Hypersensitivity reactions to small molecule drugs.小分子药物过敏反应。
Front Immunol. 2022 Nov 10;13:1016730. doi: 10.3389/fimmu.2022.1016730. eCollection 2022.